Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Kathryn Wood has been awarded a visiting professorship from the National University Centre for Organ Transplantation (NUCOT) at the National University Hospital in Singapore. The appointment will officially commence in October for a term of five years.

Professor Kathryn Wood (pictured right) with Professor A Vathsala (Co-Director, Renal Transplantation, National University Centre for Organ Transplantation, National University Hospital)
Professor Kathryn Wood (pictured right) with Professor A Vathsala (Co-Director, Renal Transplantation, National University Centre for Organ Transplantation, National University Hospital)

Professor Wood is Professor of Immunology in Oxford University’s Nuffield Department of Surgical Sciences where she runs the Transplantation Research Immunology Group.  Her research focuses on transplantation, particularly the immune response that leads to rejection and immune regulation as a strategy to achieve immunological tolerance.

NDS: What does your position involve and how will you be contributing to the work at NUCOT?

KW: Over the past year, I have been undertaking a review of transplantation research in the hospital medical school and a series of research initiatives have emerged. I have been asked to help guide and start up these initiatives. So my role is strategic. I am helping NUCOT to think through what research questions they can address which are relevant in Singapore, a strategy based on the resources to enable them to deliver on the project. I will also be involved in advanced teaching for clinical trainees and transplant fellows.

NDS: How will the visiting professorship benefit you and your research at Oxford?

KW: NUCOT has access to molecular profiling for assessing patients receiving a transplant that isn’t as easily accessible here. It may allow us to introduce new approaches in the future to benefit the Oxford Transplant Centre. And, as I am representing Oxford, it will help to further develop our international profile, collaborations and relationships.

NDS: You have visited NUCOT three times over the past year. What have been your highlights so far?

Seeing the scope of the technology that is available, making new contacts and inspiring NUCOT to do great research.

NDS: How are you finding Singapore?

KW: It is a very different culture and environment. It is always good to explore different cultures yourself and to see the way people work. Gaining an understanding of different cultures means it is easier to welcome visitors and students from other countries and to help them settle in to Oxford. 

Similar stories

Cochrane ENT awarded NIHR funding for COVID-19 project

Awards and appointments Coronavirus COVID-19 Research

Cochrane ENT at the Nuffield Department of Surgical Sciences has been awarded funding by the National Institute for Health Research (NIHR) to complete a suite of living systematic reviews investigating the effectiveness and safety of interventions to prevent and treat loss of smell after COVID-19 infection.

First peer-reviewed results of phase 3 human trials of Oxford coronavirus vaccine demonstrate efficacy

Coronavirus COVID-19 Publication Research

Today University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials of a vaccine against SARS-CoV-2 across two different dose regimens, resulting in an average efficacy of 70.4%.

Applications for Oxford-Wolfson-Marriott-Patel Scholarship now open

Awards and appointments Department Research

The Nuffield Department of Surgical Sciences (NDS) are pleased to confirm that one scholarship will be available for Home (UK) and Republic of Ireland (ROI) candidates for the DPhil in Surgical Sciences, starting in Michaelmas Term 2021.

Oxford University breakthrough on global COVID-19 vaccine

Coronavirus COVID-19 Research

The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.

Transplant kidney survival rate improves with new method of transportation

Publication Research

New research by the Consortium for Organ Preservation in Europe (COPE) has found that a new method to transport donor kidneys, which uses a combination of cold perfusion with oxygen, can significantly improve transplant results, with less graft failure, better function and lower rejection of the kidney when compared to cold perfusion alone. For patients who need a kidney transplant this is a big step forward. The study, carried out in Belgium, The Netherlands and the UK, was published today in The Lancet.

Breast cancer study wins 2020 ONS Research Excellence Award

Awards and appointments Research

Dr Gurdeep Mannu from the Nuffield Department of Surgical Sciences, University of Oxford, has won the Office for National Statistics (ONS) Research Excellence Award for a study which highlighted early risk factors for breast cancer patients.